Methyl cap binding protein 2: a key epigenetic protein in systemic sclerosis

Henderson, J., Brown, M., Horsburgh, S., Duffy, L., Wilkinson, S., Worrell, J. , Stratton, R. and O’Reilly, S. (2018) Methyl cap binding protein 2: a key epigenetic protein in systemic sclerosis. Rheumatology, 58(3), pp. 527-535. (doi: 10.1093/rheumatology/key327) (PMID:30462328)

Full text not currently available from Enlighten.

Abstract

Objective: SSc is an autoimmune connective tissue disease that results in skin fibrosis and currently has no effective treatment. Epigenetic modifications have been described and these may be key in initiating and driving fibroblast activation. Among these epigenetic modifications methylation may be of central importance. The aim of this study was to examine the role of methyl cap binding protein-2 (MeCP2) in SSc fibrosis. Methods: We used healthy and SSc dermal fibroblasts to examine the role of MeCP2, using both small interfering RNA silencing and lentiviral overexpression to determine its effects. We also examined the expression of MeCP2 in SSc fibroblasts by immunoblotting. miRNA132 was quantified by Taqman real time PCR. Results: We demonstrated that TGF-β1 induced the expression of MeCP2 in normal cells, and showed that SSc fibroblasts expressed high levels of MeCP2 under basal conditions. MeCP2 positively regulated the expression of extracellular matrix through epigenetic repression of the Wnt antagonist sFRP-1, leading to enhanced Wnt signalling. This mediated fibrosis through glycolysis, as the glycolysis inhibitor 2-deoxyglucose diminished the Wnt-mediated collagen expression. MiR132 expression was reduced in SSc fibroblasts. Conclusion: The results suggest that an epigenetic loop exists mediating fibrosis. Targeting of MeCP2, as a key epigenetic regulator, may be a promising therapeutic approach, as would targeting the metabolic reprogramming that occurs through aerobic glycolysis.

Item Type:Articles
Additional Information:The Rosetrees trust provided some funding for this work.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Worrell, Dr Julie
Authors: Henderson, J., Brown, M., Horsburgh, S., Duffy, L., Wilkinson, S., Worrell, J., Stratton, R., and O’Reilly, S.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:Rheumatology
Publisher:Oxford University Press
ISSN:1462-0324
ISSN (Online):1462-0332

University Staff: Request a correction | Enlighten Editors: Update this record